Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Overview of Study Designs in Clinical Research - DocsLib
Ledidi | Overview of clinical study designs
Figure 2, FIDELIO and FIGARO Study Design - Finerenone (Kerendia ...
Finerenon FINE ARTS In Heart failure with preserved ejection fraction ...
Algorithm for Classifying the Study Design of Primary Studies ...
13 Awesome Study Room Design Ideas and Decoration Tips in 2023
Why is the choice of study design important?
8 Perfect Study Table Design Ideas For Adults & Kids
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study ...
A randomized controlled study of finerenone vs. eplerenone in patients ...
Finerenone in patients with heart failure with mildly reduced or ...
Rationale and design of a randomised phase III registration trial ...
Clinical utility and safety of finerenone in patients with heart ...
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in ...
Heart Failure Clinical Trials & Pipeline | Bayer USMA
Frontiers | The significance of finerenone as a novel therapeutic ...
New Research Explores Benefits of Finerenone in Patients With HFmrEF or ...
FINERENONE The Novel non-steroidal MRA.pptx
曹承榮: 必看！2024 最重要突破 Finerenone (Kerendia)： 真正顧腎、保心的藥物又多了一個，你怎能不知道
(PDF) Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN ...
Early Clinical Experience of Finerenone in People with Chronic Kidney ...
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin ...
Design and Baseline Characteristics of the Finerenone in Reducing ...
The potential role of finerenone in patients with type 1 diabetes and ...
FIDELIO-DKD (Journal Club) – My Endo Consult
Finerenone: Potential Clinical Application Across the Spectrum of ...
Figure 1 from Design of the COmbinatioN effect of FInerenone anD ...
Finerenone (1.25 mg) and erythromycin (500 mg t.i.d.) co‐administration ...
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or ...
FINEARTS- HF TRIAL Finerenone in HF.pptx
Finerenone in heart failure and chronic kidney disease with type 2 ...
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly ...
Frontiers | A comprehensive examination and analysis of the ...
(PDF) Investigating the use of finerenone in children with chronic ...
First interim results from FINE-REAL: a prospective, non-interventional ...
(PDF) Finerenone cardiovascular and kidney outcomes by age and sex ...
(PDF) Finerenone in Patients With Chronic Kidney Disease and Type 2 ...
Mechanistic Understanding of Finerenone in Hypertension Management: A ...
Finerenone – Application in Therapy and Current Clinical Research
Design and baseline characteristics of the Finerenone, in addition to ...
(PDF) Design and Baseline Characteristics of the Finerenone in Reducing ...
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With ...
FIND-CKD and Next Steps for Finerenone Research With George Bakris, MD
Dosing, treatment patterns and safety of finerenone use in routine care ...
Finerenone in Diabetic Nephropathy — NephJC
Finerenone: Questions and Answers—The Four Fundamental Arguments on the ...
CONFIDENCE_Trial_Finerenone_Empagliflozin_Presentation.pptx
Investigating the use of finerenone in children with chronic kidney ...
A prespecified exploratory analysis from FIDELITY examined finerenone ...
Frontiers | Overview of the safety, efficiency, and potential ...
Efficacy and Safety of Finerenone in Chronic Kidney Disease: A ...
Finerenone and new-onset diabetes in heart failure: a prespecified ...
HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HF ...
PPT FINERENONE PowerPoint presentation 1 | PPTX
The use of a novel non-steroidal mineralocorticoid receptor antagonist ...
Results of ARTS-HF finerenone versus eplerenone in patients
Rationale and design of an investigator-initiated, multicenter ...
Frontiers | Finerenone in type 2 diabetes and renal outcomes: A random ...
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The ...
Finerenone in chronic kidney disease and type 2 diabetes: the known and ...
Finerenone: A Third-Generation MRA and Its Impact on Cardiovascular ...
Finerenone in patients with chronic kidney disease and type 2 diabetes ...
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY ...
Finerenone in Heart Failure—A Novel Therapeutic Approach
| Serum potassium monitoring during treatment with finerenone. Adapted ...
The FINEARTS-HF Trial: Exploring Finerenone’s Efficacy and Safety in ...
(PDF) Efficacy and Safety of Finerenone in Chronic Kidney Disease: A ...
Potassium management with finerenone: Practical aspects - Wanner - 2022 ...
Effects of Finerenone on Readmissions for Heart Failure: Insights from ...
(PDF) Finerenone Versus Placebo on Renal Outcomes in Patients with ...
Simulated finerenone drug interactions (strong colors) with the ...
A comprehensive examination and analysis of the effectiveness and ...
(PDF) Rationale and design of an investigator-initiated, multicenter ...
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis ...
Kidney phenotyping of age-matched control mice (control), diabetic high ...
VPC of finerenone PK profiles for a representative subset of considered ...
A comparative post hoc analysis of finerenone and spironolactone in ...
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes ...
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc ...
Frontiers | Association of finerenone with prognosis and safety in ...
Pharmacotherapy considerations with finerenone in the treatment of ...
(PDF) Finerenone: A Potential Treatment for Patients with Chronic ...
Finerenone Reduces Risk of Incident Heart Failure in Patients With ...
WO2023205164A1 - Processes for the preparation of finerenone - Google ...
Finerenone Versus Placebo on Renal Outcomes in Patients with Chronic ...
Cardiovascular and kidney outcomes with finerenone in patients with ...
Simulated and observed finerenone AUCR (a) and CmaxR (b) and their ...
00309-7/asset/e40a51c0-24b8-4e5c-a056-d6507d7c8b1c/main.assets/gr3.jpg)
00309-7/asset/817ba96c-b44d-4b33-9b89-d5fe50999592/main.assets/gr1_lrg.jpg)
00309-7/asset/55c75d5c-fb67-47f6-aad7-fa3862849fd0/main.assets/gr2_lrg.jpg)
